MaxCyte Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Maher Masoud

Chief executive officer

US$890.4k

Total compensation

CEO salary percentage50.5%
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure2.9yrs

Recent management updates

Recent updates

Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term

Mar 14
Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Mar 07
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Analysts Have Just Cut Their MaxCyte, Inc. (LON:MXCT) Revenue Estimates By 22%

Oct 07
Analysts Have Just Cut Their MaxCyte, Inc. (LON:MXCT) Revenue Estimates By 22%

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Aug 12
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

MaxCyte, Inc. (LON:MXCT) Analysts Just Slashed This Year's Revenue Estimates By 11%

May 15
MaxCyte, Inc. (LON:MXCT) Analysts Just Slashed This Year's Revenue Estimates By 11%

Investors Don't See Light At End Of MaxCyte, Inc.'s (LON:MXCT) Tunnel And Push Stock Down 28%

May 14
Investors Don't See Light At End Of MaxCyte, Inc.'s (LON:MXCT) Tunnel And Push Stock Down 28%

We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Apr 27
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth

Nov 20
Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Mar 02
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Nov 17
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

We're Not Worried About MaxCyte's (LON:MXCT) Cash Burn

Jul 25
We're Not Worried About MaxCyte's (LON:MXCT) Cash Burn

MaxCyte (LON:MXCT) Shareholders Have Enjoyed A Whopping 545% Share Price Gain

Feb 22
MaxCyte (LON:MXCT) Shareholders Have Enjoyed A Whopping 545% Share Price Gain

If You Had Bought MaxCyte (LON:MXCT) Shares A Year Ago You'd Have Earned 249% Returns

Nov 24
If You Had Bought MaxCyte (LON:MXCT) Shares A Year Ago You'd Have Earned 249% Returns

CEO Compensation Analysis

How has Maher Masoud's remuneration changed compared to MaxCyte's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$890kUS$450k

-US$38m

Sep 30 2023n/an/a

-US$37m

Jun 30 2023n/an/a

-US$33m

Mar 31 2023n/an/a

-US$30m

Dec 31 2022US$791kUS$413k

-US$24m

Compensation vs Market: Maher's total compensation ($USD890.37K) is about average for companies of similar size in the UK market ($USD1.04M).

Compensation vs Earnings: Maher's compensation has increased whilst the company is unprofitable.


CEO

Maher Masoud (47 yo)

less than a year

Tenure

US$890,365

Compensation

Mr. Maher Masoud is President, CEO & Director of MaxCyte, Inc. since January 1, 2024 and served as its Head of Global Business Development and Legal Officer since November 2023 and had been its Secretary s...


Leadership Team

NamePositionTenureCompensationOwnership
Maher Masoud
Presidentless than a yearUS$890.37kno data
Douglas Doerfler
Founder25.8yrsUS$3.14m0.32%
$ 982.9k
Douglas Swirsky
Chief Financial Officer1.2yrsUS$1.29mno data
Jay Gelfman
Senior Vice President of Operationsless than a yearno datano data
Ronald Holtz
Executive Vice President of Administration1.2yrsUS$948.33kno data
David Sandoval
Senior Vice Presidentless than a yearno datano data
Thomas Ross
Executive Vice President of Global Sales9.7yrsno datano data
Jack Horgan
Vice President of Corporate Developmentless than a yearno datano data
Jill Mayer
Senior Vice President of Human Resourcesless than a yearno datano data
J. Thompson
Consultant2.6yrsUS$264.50kno data
James Brady
Senior VP of Technical Applications & Customer Support2.8yrsno datano data
Ali Soleymannezhad
Executive VP of Bioprocessingless than a yearno datano data

1.0yrs

Average Tenure

63.5yo

Average Age

Experienced Management: MXCT's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Maher Masoud
Presidentless than a yearUS$890.37kno data
William Brooke
Independent Non-Executive Director20.2yrsUS$177.24k0.048%
$ 148.4k
Arthur Mandell
Independent Non-Executive Director18yrsUS$170.49k0.36%
$ 1.1m
Patrick Balthrop
Independent Non-Executive Director1.5yrsUS$155.49kno data
Richard Douglas
Independent Non-Executive Chairman of the Board6.3yrsUS$190.49k0.096%
$ 295.0k
Stanley Erck
Independent Non-Executive Director19.2yrsUS$162.24k0.24%
$ 730.9k
John Johnston
Independent Non-Executive Director8.3yrsUS$160.49k0.12%
$ 355.7k
Yasir Al-Wakeel
Independent Non-Executive Director2.9yrsUS$238.53k0%
$ 0
Rehka Hemrajani
Independent Non-Executive Director2.9yrsUS$243.03k0%
$ 0
Marcela Maus
Member of Scientific Advisory Board1.2yrsno datano data
Cenk Sumen
Member of Scientific Advisory Boardless than a yearUS$897.25k0%
$ 0
Oliver Rando
Member of Scientific Advisory Board1.2yrsno datano data

2.9yrs

Average Tenure

64yo

Average Age

Experienced Board: MXCT's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.